Phase I Trial of Oral Irinotecan and Temozolomide for Children With Relapsed High-Risk Neuroblastoma: A New Approach to Neuroblastoma Therapy Consortium Study
Wagner, L. M., Villablanca, J. G., Stewart, C. F., Crews, K. R., Groshen, S., Reynolds, C. P., Park, J. R., Maris, J. M., Hawkins, R. A., Daldrup-Link, H. E., Jackson, H. A., Matthay, K. K.Volume:
27
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2008.18.5918
Date:
March, 2009
File:
PDF, 96 KB
english, 2009